Roche Acquires Spark Therapeutics, Inc. in Another Large Biotech Deal

It’s been a busy year for the biotechnology sector so far, and this week continued the trend. Roche (SIX: RO), the global pharmaceuticals and diagnostics company, acquired Spark Therapeutics, Inc. (NASDAQ: ONCE) for $4.3 billion. At $114.50 per share, the price represents a 122% premium to Spark’s closing price on February 22, 2019, and a 19% premium to Spark’s […]

Biotechnology and Digital Health Deals Lead for December

Although December is typically one of the slower months in transaction announcements, the eHealth and Biotechnology sectors remained the most active with a total of 27 transactions, growing in proportion compared to December 2017. Biotechnology and e-Health transactions were roughly 19% of all of December 2017’s deals, but they were 28% this December. However, price volume tells […]